Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Control Groups × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 11 Neoplasms 7 Motor Activity 5 Pain, Postoperative 4 Stomach Neoplasms 3 Vomiting 2 Nausea 2 Lung Neoplasms 2 Liver Diseases 2 Fatigue 2 Colorectal Neoplasms 2 Chronic Pain 2 Cancer Pain 2 Agnosia 2 Uterine Cervical Neoplasms 1 Ulcer 1 Stomatitis 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Initiation and Maintenance Disorders 1 Rectal Neoplasms 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Peripheral Nervous System Diseases 1 Pediatric Brain Tumor 1 Pathologic Processes 1 Papillomavirus Infections 1 Pain 1 Osteolysis 1 Neuroendocrine Tumors 1 Nasopharyngeal Carcinoma 1

Interventions

Cyclophosphamide 11 blinatumomab 8 fludarabine 7 venetoclax 6 fludarabine phosphate 5 Cytarabine 5 Rituximab 4 Lenalidomide 4 Dexamethasone 4 Blood Specimen Collection 4 Azacitidine 4 obinutuzumab 3 daratumumab 3 pembrolizumab 2 nilotinib 2 Vincristine 2 Radiotherapy 2 Methotrexate 2 Melphalan 2 Immunotherapy, Adoptive 2 Imatinib Mesylate 2 Idarubicin 2 Daunorubicin 2 Dasatinib 2 Chemotherapy, Adjuvant 2 Capecitabine 2 trastuzumab deruxtecan 1 tislelizumab 1 tisagenlecleucel 1 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡